Healthcare
Ramsay Health Care Limited(RMSYF)
Live Price
Offline$24.61
+0.00% today
1Y Change
-2.53%
Window
Jun 20, 2025 โ Jun 12, 2026
- Market Cap
- $8.80B
- Revenue Growth
- +6.7%
- EPS Growth
- -97.3%
- Dividend Yield
- 2.2%
Coverage: 246 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ramsay Health Care Limited (RMSYF) is a Healthcare stock with a market cap of $8.80B and listed on OTC. The stock last traded around $24.61 and down 2.5% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +6.7%, EPS growth of -97.3%, a dividend yield of 2.2%. What stands out right now is revenue +6.7%, EPS -97.3%, free cash flow +30.6% with operating margin 8.5% and ROIC 5.7%. The dividend is present but secondary, with a yield around 2.2%. Valuation already assumes a fairly strong business story at P/E 30.4 and price/sales 0.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RMSYF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+6.7% vs +7.6% peer median
Operating Margin
Below sector median
+8.5% vs +19.4% peer median
P/E
Below sector median
30.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
2026 was reported on Feb 25, 2026 with an EPS surprise of +19.0% and a revenue surprise of +1.4%.
The operating picture looks softer than before
Revenue is at +6.7% and EPS is at -97.3%, with operating margin around 8.5%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 27, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.1% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 25, 2026 | +19.0% | +0.0% | +0.0% | +0.0% |
2025 Aug 27, 2025 | -15.9% | +0.0% | +0.0% | +0.0% |
2025 Feb 27, 2025 | -173.3% | +0.0% | -0.3% | -0.3% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RMSYF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RMSYF Max Drawdown
-21.60%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RMSYF and SPY.
Company Overview
Ramsay Health Care Limited
Other OTC
Ramsay Health Care Limited owns and operates hospitals. The company also offers health care services to public and private patients. It operates facilities in approximately 532 locations in the Asia Pacific, the United Kingdom, France, and Nordics. The company was founded in 1964 and is based in Sydney, Australia.
- Leadership
- Natalie Davis
- IPO Date
- Jun 9, 2010
- Employees
- 90.0k
- Street Address
- 126 Phillip Street
- Mailing
- Sydney, NSW, 2000
- Region
- Sydney, NSW, AU
- Reporting Currency
- USD
- Investor Line
- 61 2 9220 1000
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 30.4
- EV/EBITDA
- 15.6
- Price/Sales
- 0.5
- Price/Book
- 1.7
Growth
- Revenue
- +6.7%
- EPS
- -97.3%
- Free Cash Flow
- +30.6%
Profitability
- Gross Margin
- 10.6%
- Operating Margin
- 8.5%
- Net Margin
- 1.6%
- ROE
- 5.8%
- ROIC
- 5.7%
Balance Sheet
- Debt/Equity
- 3.48
- Current Ratio
- 0.90
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.